Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MediWound Ltd. - Ordinary Shares
(NQ:
MDWD
)
14.16
+0.77 (+5.75%)
Delayed Quote
Updated: 2:08 PM EST, Nov 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MediWound Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
November 03, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Third Quarter 2026 Financial Results
October 29, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
September 22, 2026
From
MediWound Ltd.
Via
GlobeNewswire
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
September 14, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 02, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd. (NASDAQ:MDWD) Q1 2026: Revenue Miss but Narrower Loss, Full-Year Outlook Intact
↗
May 27, 2026
Via
Chartmill
MediWound Ltd. (NASDAQ:MDWD) Reports Q4 2025 Revenue Miss Despite Pipeline Progress
↗
March 05, 2026
Via
Chartmill
MediWound (MDWD) Q2 2026 Earnings Call Transcript
↗
August 20, 2026
EscharEx advances Phase III enrollment while manufacturing facility nears regulatory completion.
Via
The Motley Fool
Topics
Earnings
MediWound Q2 Earnings Call Highlights
↗
August 13, 2026
MediWound (NASDAQ:MDWD) reported second-quarter 2026 revenue of $3.1 million, down from $5.7 million a year earlier, as the company continued investing in its Phase III EscharEx chronic-wound program...
Via
MarketBeat
Topics
Earnings
MediWound Q2 2026 Earnings Call: Complete Transcript
↗
August 13, 2026
MediWound (NASDAQ:MDWD) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts...
Via
Benzinga
Topics
Earnings
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Second Quarter 2026 Financial Results
July 29, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound (MDWD) Q1 2026 Earnings Transcript
↗
May 27, 2026
MediWound (MDWD) Q1 2026 Earnings Transcript
Via
The Motley Fool
MediWound Q1 Earnings Call Highlights
↗
May 27, 2026
MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance...
Via
MarketBeat
Topics
Earnings
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report First Quarter 2026 Financial Results
May 07, 2026
From
MediWound Ltd.
Via
GlobeNewswire
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
April 13, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
April 07, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
April 02, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Files Annual Report on Form 20-F
March 05, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound (MDWD) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
MediWound (MDWD) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present at Upcoming Investor Conferences
February 17, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
January 12, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
December 10, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd (NASDAQ:MDWD) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates
↗
November 20, 2025
MediWound's Q3 2025 results show revenue miss but a smaller-than-expected loss. The company advances its EscharEx pipeline and expands NexoBrid manufacturing.
Via
Chartmill
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 20, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Examining the Future: MediWound's Earnings Outlook
↗
November 19, 2025
Via
Benzinga
Earnings Scheduled For November 20, 2025
↗
November 20, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
